Prelude Therapeutics Incorporated

NASDAQ:PRLD

Biotechnology

Healthcare
$3.32 -3.22%

-$0.14 today

Market cap
$192.16M
Beta
1.01
P/E (TTM)
-4.5
EPS (TTM)
-$0.94
52W Low $0.75High $5.54

Volume 0.42M

Average 0.38M

Price history

Prelude Therapeutics Incorporated SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+97.62%

Period high

$6.63

Period low

$1.35

Latest

$3.32

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KSep 10, 2026Sep 10, 2026
10-QAug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
SC 13GJul 8, 2026Jul 8, 2026
4Jun 10, 2026Jun 10, 2026
4Jun 10, 2026Jun 10, 2026
4Jun 10, 2026Jun 10, 2026
4Jun 10, 2026Jun 10, 2026
4Jun 10, 2026Jun 10, 2026
8-KJun 10, 2026Jun 10, 2026
4Jun 10, 2026Jun 10, 2026
8-KMay 12, 2026May 12, 2026
10-QMay 12, 2026May 12, 2026
4May 4, 2026May 4, 2026
DEFA14AApr 29, 2026Apr 29, 2026

Competitors

Who does Prelude Therapeutics Incorporated compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about PRLD's filings, answered from its disclosures.

What is the latest PRLD filing?

The latest filing shown is 8-K dated Sep 10, 2026.

How many recent filings does PRLD have?

Intrinsic Alpha currently shows 20 recent filings for PRLD.